Site navigation

Navigation

Breast cancer - gemcitabine

Gemcitabine for the treatment of metastatic breast cancer

Summary

Gemcitabine, which is combined with another medicine called paclitaxel to treat metastatic breast cancer, is only recommended as a possible treatment for people with metastatic breast cancer in situations where two other treatments could also be used as alternatives. Other treatments that doctors co ...

Read the complete summary


Guidance documents

Implementing this guidance

We will consult on our review plans for this guidance in January 2010

About this guidance

Technology appraisals TA116

Issued: January 2007

See related guidance:

See this guidance in practice:

Order printed copies of this guidance